The biotechnology firm reported a loss per share of 21 cents, surpassing the estimated loss of 27 cents. Additionally, Recursion’s revenue reached $35.54 million in the quarter, well above the ...

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Anthropic’s artificial-intelligence tool Claude was used in the U.S. military’s operation to capture former Venezuelan President Nicolás Maduro, highlighting how AI models are gaining traction in the ...

Exclusive: Mark Aitken, who worked in the sector for 16 years, said eight times out of 10 he disagreed with the integrated assessment tool Follow our Australia news live blog for latest updates Get ...